John E. Leonard - Mar 31, 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
SVP, Development
Signature
/s/ Scott E. Royer, Attorney-in-Fact for John E. Leonard
Stock symbol
VCNX
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/3/2023, 04:35 PM
Previous filing
Apr 4, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 2.26K Mar 31, 2023 Direct
holding VCNX Common Stock 1.01K Mar 31, 2023 By John Leonard Consulting, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +20K $0.00 20K Mar 31, 2023 Common Stock 20K $0.40 Direct F5
holding VCNX Stock Option (Right to Buy) 23.2K Mar 31, 2023 Common Stock 23.2K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 3.06K Mar 31, 2023 Common Stock 3.06K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 3K Mar 31, 2023 Common Stock 3K $3.90 Direct F1
holding VCNX Stock Option (Right to Buy) 4K Mar 31, 2023 Common Stock 4K $6.07 Direct F2
holding VCNX Stock Option (Right to Buy) 8K Mar 31, 2023 Common Stock 8K $2.93 Direct F3
holding VCNX Stock Option (Right to Buy) 16K Mar 31, 2023 Common Stock 16K $1.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable in full as of the date of this report.
F2 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.
F3 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
F4 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
F5 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date.